COVID-19-Associated Retroperitoneal Hemorrhage: Same Complication, Two Different Types of Treatment

One of the reasons for the high mortality in COVID-19 patients is the increased risk of disseminated intravascular coagulation (DIC) and venous thromboembolism. For this reason, the use of anticoagulant treatments has become widespread. One of the rare complications of anticoagulant therapy is retro...

Full description

Saved in:
Bibliographic Details
Published inGrand journal of urology (Online)
Main Authors Aydın Yoldemir, Sengül, Kibar Akıllı, Işıl, Bilge, Müge, Canbolat Unlu, Esra, izmir Güner, Şebnem, Güner, Ekrem, Kart Yaşar, Kadriye
Format Journal Article
LanguageEnglish
Published 2021
Online AccessGet full text

Cover

More Information
Summary:One of the reasons for the high mortality in COVID-19 patients is the increased risk of disseminated intravascular coagulation (DIC) and venous thromboembolism. For this reason, the use of anticoagulant treatments has become widespread. One of the rare complications of anticoagulant therapy is retroperitoneal hemorrhage. These hemorrhagies require immediate intervention. Retroperitoneal hemorrhage should be kept in mind among the many complications that develop in the patient who was followed up during the pandemic period. For this purpose, we present 2 cases who developed spontaneous retroperitoneal bleeding while clinically recovering under COVID-19 treatment.
ISSN:2757-7163
2757-7163
DOI:10.5222/GJU.2021.79188